John R. Wilson - 25 May 2021 Form 4 Insider Report for Allovir, Inc. (KLRS)

Role
Director
Signature
/s/ Brett Hagen, as Attorney-in-Fact
Issuer symbol
KLRS
Transactions as of
25 May 2021
Net transactions value
$0
Form type
4
Filing time
27 May 2021, 16:50:42 UTC
Next filing
10 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ALVR Common Stock 2,197,999 25 May 2021 See footnote F1, F2
holding ALVR Common Stock 3,164,954 25 May 2021 See footnote F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALVR Stock Option (Right to Buy) Award $0 +22,500 $0.000000 22,500 25 May 2021 Common Stock 22,500 $21.51 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Previous Section 16 reports filed by the Reporting Person have inadvertently reported certain shares of common stock as being held through multiple forms of indirect ownership. This report serves to correct and clarify that (a) 2,197,999 shares are held by Meristem Trust Company, LLC as trustee of the John R. Wilson Irrevocable Trust dated July 9, 2020 and (b) 3,164,954 shares are held by John R. Wilson, as trustee of the John R. Wilson Revocable Trust Agreement dated August 3, 2017.
F2 Shares held by Meristem Trust Company, LLC as trustee of the John R. Wilson Irrevocable Trust dated July 9, 2020, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F3 Shares held by the Reporting Person as Trustee of the John R. Wilson Revocable Trust Agreement dated August 3, 2017. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F4 This option shall vest and become exercisable upon the earlier to occur of (i) May 25, 2022 and (ii) the next annual meeting of the Issuer's stockholders.